- 首頁
- App 分析
- ePRO BI1403-0008
- ePRO BI1403-0008 Vs. Teckro
ePRO BI1403-0008 與 Teckro 使用情況與統計
Boehringer Ingelheim ePRO BI1403-0008 is intended to collect patient reported outcomes relating to a clinical trial (BI Trial 1403-0008 – Brightline-1). Patients must be given accounts by a participating site in order to log in to the app.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
Teckro transforms your clinical trial protocol into a hub of communication and collaboration. It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Drugs from trials powered by Teckro have been granted priority review and approval by regulators in the US and Europe. Thousands of investigators and 20,000+ sites around the world rely on Teckro to execute clinical trials from biopharma sponsors, including 12 out of the Top 20 pharma companies. We support all therapeutic areas, all phases, and any trial model, whether traditional, virtual, or a hybrid approach - if Teckro isn't used on your clinical trial, ask your study manager for it.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
ePRO BI1403-0008與 Teckro 比較排名
比較過去 28 天的 ePRO BI1403-0008 排名趨勢與 Teckro
排名
無可用數據
各國 ePRO BI1403-0008 vs. Teckro 排名比較
比較過去 28 天的 ePRO BI1403-0008 排名趨勢與 Teckro
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
ePRO BI1403-0008 VS.
Teckro
12月 28, 2024